Bad News Flash: Scientists Did Not Cure Autism, Cancer Or Alzheimer's
By Steven Salzberg,
Forbes
| 03. 07. 2016
This week I’m calling out some recent headlines about medical “breakthroughs” that were wildly misleading. Even when the science itself is good, bad reporting raises false hopes and eventually undermines the public’s confidence. At some point, people will just no longer believe the headlines claiming that someone has once again cured cancer.
My first example of bad news is from a couple of weeks ago. I was struck by a headline that showed up in one of my news feeds that read:
Neuroscientists reverse autism symptoms
Wow, I thought. This would be a real breakthrough if it were true. I traced the headline back to the MIT press office, where I then saw the subheading: “turning on a gene later in life can restore typical behavior in mice.” Uh oh: Extrapolating any treatment from mice to humans is fraught with problems, and studying a complex behavioral disorder like autism is even more difficult.
The HuffPo fell for it, though. Their headline read, “Some Autism Symptoms May Be Reversed By Gene Editing, Scientists Suggest.” So did the Daily Mail, which...
Related Articles
By Fyodor D. Urnov and Sadik H. Kassim, Nature | 04.21.2026
In February, the US Food and Drug Administration (FDA) proposed a radical rethink of how scientists, physicians and manufacturers develop personalized genetic therapies. The regulator’s suggested introduction of a ‘plausible mechanism pathway’ should increase incentives for drug companies to develop...
By Miguel Muñoz, Cadena SER | 08.04.2026
"Para ellos, una familia numerosa no solo es una preferencia personal, sino que es una obligación. Creen que tener tantos hijos como sea posible es necesario para evitar un futuro apocalíptico", aseguraba Xavier Orri, periodista y cofundador de Página Internacional...
By Ryan Knutson and Jessica Mendoza, The Journal. | 03.27.2026
Genetically engineered babies are banned in the U.S. But that isn’t stopping Silicon Valley tech titans from trying to make one. In this final installment from The Journal’s investigation into the fringes of the fertility industry, WSJ’s Emily Glazer reports...
By Antonio Regalado, MIT Technology Review | 03.30.2026
After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing.
In...
